Cost-effectiveness analysis of rezvilutamide versus bicalutamide and androgen-deprivation therapy in patients with high-volume, metastatic, hormone-sensitive prostate cancer: a Mar... by Juan Hong, Xiaohui Zeng, Wenjun Chen, Ziyuan Zhou, Yuming He, Jun Meng, Lihui Ouyang

Get full text